Human Genome in Talks With Potential Suitors

Human Genome Sciences Inc. said it’s in talks with “major” pharmaceutical and biotechnology companies about a potential transaction and adopted measures to avoid a hostile takeover by GlaxoSmithKline Plc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.